Welcome to our dedicated page for Northrop Grumman SEC filings (Ticker: NOC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Northrop Grumman Corporation (NOC) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, with AI-powered tools to help interpret complex documents. Northrop Grumman is a global aerospace and defense technology company, and its filings provide structured insight into its financial performance, capital structure, governance, and key agreements.
Recent Form 8-K filings illustrate the types of information investors can expect. A July 22, 2025 Form 8-K reports that Northrop Grumman issued an earnings release for the quarter ended June 30, 2025, while an October 21, 2025 Form 8-K notes the release of financial results for the quarter ended September 30, 2025. These current reports reference earnings releases furnished as exhibits, which complement the company’s quarterly reports on Form 10-Q and annual reports on Form 10-K that are also accessible through EDGAR.
Another Form 8-K dated September 2, 2025 describes a material definitive agreement: a five-year senior unsecured revolving credit facility intended to support the company’s commercial paper program and other general corporate purposes. The filing outlines key covenants, including a maximum consolidated debt-to-capitalization ratio and customary events of default. A November 6, 2025 Form 8-K details a chief financial officer transition and related compensation decisions approved by the Compensation and Human Capital Committee.
On this page, Stock Titan surfaces such filings in real time and applies AI-powered summaries to explain the significance of documents like 10-K annual reports, 10-Q quarterly reports, and 8-K current reports. Users can also review disclosures related to material agreements and leadership changes, and locate information that may be relevant to insider transactions reported on Form 4. The goal is to make Northrop Grumman’s regulatory record easier to navigate by highlighting key sections and translating technical language into more accessible explanations.
Northrop Grumman director Mark A. Welsh III sold 95 shares of common stock in pre-planned transactions. On May 4, 2026, he executed 11 open-market sales at prices between $566.60 and $577.05 per share under a Rule 10b5-1 trading plan adopted on August 23, 2025. After these sales, he directly owned 4,121 Northrop Grumman shares.
Northrop Grumman Corp ownership filing shows Vanguard Capital Management beneficially owned 10,248,540 shares of Common Stock, representing 7.22% of the class as of 03/31/2026. The filing reports sole dispositive power over 10,248,540 shares and sole voting power for 1,299,313 shares. The disclosure attributes holdings to Vanguard Capital Management and specified Vanguard affiliates and notes these include securities held by Vanguard funds and managed accounts.
Northrop Grumman Corporation registered a shelf on Form S-3 to offer senior debt securities and common stock. The prospectus dated April 21, 2026 describes a shelf registration permitting sales from time to time, with specific terms and amounts to be provided in prospectus supplements.
The prospectus states proceeds will be used for general corporate purposes, including repayment of debt, share repurchases, working capital, capital expenditures and acquisitions. The filing incorporates by reference the company’s recent SEC reports and identifies The Bank of New York Mellon as indenture trustee for senior debt.
Northrop Grumman’s first quarter 2026 results show sharply higher profitability on modest sales growth. Sales rose 4% to $9.9 billion, while operating income jumped to $989 million from $573 million as operating margin expanded to 10.0% from 6.1%.
Net earnings increased 82% to $875 million and diluted EPS climbed to $6.14 from $3.32, helped by the absence of the large B‑21 loss charge recorded a year earlier and stronger segment performance, particularly in Aeronautics and Mission Systems.
Backlog remained very strong at $95.6 billion, with about 60% expected to turn into revenue within 24 months. Free cash flow was negative $1.8 billion, reflecting typical first‑half working capital usage and continued investment, including capacity expansion on the B‑21 program.
Northrop Grumman reported strong first quarter 2026 results, with sales up 4% to $9.9 billion and diluted EPS up 85% to $6.14. Net earnings rose 82% to $875 million, driven mainly by much higher operating income and pension benefits versus last year’s B‑21 loss provision.
Segment operating income nearly doubled, lifting the segment margin from 6.0% to 10.8%, led by Aeronautics Systems and Mission Systems. Space Systems saw lower sales and margins due to the NGI wind‑down and a $71 million GEM 63XL charge. Free cash flow was a use of $1.8 billion, similar to last year, reflecting typical first‑half working capital timing. The company ended the quarter with $95.6 billion of backlog and reaffirmed its 2026 guidance for sales, segment operating income, MTM‑adjusted EPS and free cash flow.
Northrop Grumman Corporation is asking shareholders to vote at its 2026 virtual annual meeting on 11 director nominees, executive pay, auditor ratification, and a shareholder proposal for an independent board chair, which the Board recommends voting against.
For 2025, sales rose 2% to $42 billion, with organic sales up 3% and operating margin reaching 10.8%. Diluted EPS was $29.08, with mark-to-market adjusted EPS of $26.34, exceeding guidance. The company ended 2025 with record backlog of $95.7 billion and generated $4.8 billion in operating cash flow and $3.3 billion in free cash flow, while increasing its quarterly dividend by 12%.
The proxy emphasizes strong board independence (about 92% independent directors), a lead independent director with extensive responsibilities, proxy access rights, and majority voting for directors. Executive compensation is heavily performance-based, with over 80% variable pay and non-financial metrics tied to customers, people, and environmental sustainability.
Northrop Grumman director Marianne Catherine Brown reported acquiring 68 shares of common stock valued at $682.24 per share on a deferred basis. The shares were credited to a stock unit account under the Northrop Grumman 2024 Long-Term Incentive Stock Plan in a transaction exempt under Rule 16b-3. Following this award, she holds 11,066 shares of common stock, including dividends, in the stock unit account pursuant to the plan. This reflects routine equity-based compensation rather than an open‑market stock purchase.
Northrop Grumman director Arvind Krishna reported an acquisition of 53 shares of common stock, valued at $682.24 per share, as a grant deferred into a stock unit account under the Northrop Grumman 2024 Long-Term Incentive Stock Plan. Following this compensation-related award, Krishna directly holds 2,317 shares of common stock.